Diabetic foot care references

The following references are provided in the context of the diabetic foot care we offer.

  1. American Diabetes Association. Consensus development conference on diabetic foot wound care: 7-8 April 1999, Boston, Massachusetts. Diabetes Care 22(8):1354-60, 1999.
  2. National Hospital Discharge Survey, 1996. Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Health Care Statistics. Data computed by the Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion.
  3. U.S. Department of Health and Human Services: Healthy People 2010. In National Health Promotion and Disease Prevention Objectives. Washington, D.C., U.S. Govt. Printing Office, January 2000.
  4. Lavery LA, Ashry HR, van Houtum W, et al. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 19(1):48-52, 1996.
  5. Lavery LA, van Houtum WH, Ashry HR, et al. Diabetes-related lower extremity amputations disproportionately affect Blacks and Mexican Americans. Southern Medical Journal 92(6):593-9,1999.
  6. Nelson RG, Ghodes DM, Everhart JE, et al. Lower-extremity amputations in NIDDM: 12-year follow-up study in Pima Indians. Diabetes Care 11:8-16, 1988.
  7. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In Diabetes in America. 2nd ed., National Institutes of Health, NIDDK, NIH Pub. No. 95-1468, 1995.
  8. Behavioral Risk Factor Surveillance System, 1996. Centers for Disease Control and Prevention, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion.
  9. Tomar, SL, Lester, A. Dental and other health care visits among US adults with diabetes. Diabetes Care, under review, 2000.
  10. Kenny SJ, Smith PJ, Goldschmid MG, et al. Survey of physician practice behaviors related to diabetes mellitus in the U.S: Physician adherence to consensus recommendations. Diabetes Care 16(11):1507-10, 1993.
  11. Levin ME. Preventing amputation in the patient with diabetes. Diabetes Care 18:1383-94, 1995.
  12. Reiber G, the Diabetes Ulcer Outcome Study Group: Treatment and outcomes of diabetic foot ulcers. (Abstr.) Diabetes S146(Suppl):45, 1997.
  13. Mayfield JA, Reiber GE, Sanders LJ, et al. Preventive foot care in people with diabetes (Technical Review). Diabetes Care 21(12):2161-77, 1998.
  14. Palumbo PJ, Melton LJ. Peripheral vascular disease in diabetes. In Diabetes in America. Harris MI, Hamman RF, Eds. Bethesda, Md., National Diabetes Data Group, NIH Pub. No. 85-1468, 1985, p.1-21.
  15. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22(3):382-8, 1999.
  16. del Aguila MA, Reiber GE, Koepsell TD. How does provider and patient awareness of high-risk status for lower extremity amputation influence foot-care practice? Diabetes Care 17(9):1050-54, 1994.
  17. Adler AI, Boyko EJ, Ahroni JH, et al. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 22(7):1029-35, 1999.
  18. Mayfield JA, Reiber GE, Nelson RG, et al. A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care 19(7):704-9, 1996.
  19. Murray HJ, Young MJ, Hollis S, et al. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabetic Medicine 13(11):979-82, 1996.
  20. Lehto S, Pyorala K, Ronnemaa T, et al. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 19(6):607-12, 1996.
  21. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329 (14):977-86, 1993.
  22. The Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. New England Journal of Medicine 342(6):381-9, 2000.
  23. United Kingdom Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-53, 1998.
  24. Reducing the Health Consequences of Smoking: 25 Years of Progress: A report of the Surgeon General 1989. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health, Rockville, MD 20857. 1989, pp. 63-65.
  25. Shaw JE, van Schie CH, Carrington AL, et al. An analysis of dynamic forces transmitted though the foot in diabetic neuropathy. Diabetes Care 21(11):1955-9, 1998.
  26. Katoulis EC, Ebdon-Parry M, Lanshammar H, et al. Gait abnormalities in diabetic neuropathy. Diabetes Care 20(12): 1904-7, 1997.
  27. Van Deursen RW, Simoneau GG. Foot and ankle sensory neuropathy, proprioception, and postural stabilit y. Journal of Orthopedic Sports Physical Therapy 29(12): 718-26, 1999.
  28. Katoulis EC, Ebdon-Parry M, Hollis, S. Postural instability in diabetic neuropathic patients at risk for foot ulceration. Diabetic Medicine 14(4): 296-300, 1997.
  29. Cavanagh PR, Derr JA, Ulbrecht JS, et al. Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabetic Medicine 9:469-74, 1992.
  30. Shaw JE, Boulton AJ. The pathogenesis of diabetic foot problems: An overview. Diabetes 46(Suppl. 2) : S58-S61, 1997.
  31. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 13(5): 513-21, 1990.
  32. Isakov E, Susak Z, Budoragin N, et al. Self injury resulting in amputation among vascular patients: A retrospective epidemiological study. Disability and Rehabilitation 14:78-80, 1992.
  33. Apelqvist J, Larsson J, Agardh CD. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. Journal of Diabetes Complications 4(1):21-5, 1990.
  34. Sanders LJ: Diabetes mellitus- prevention of amputation. Journal of the American Podiatric Medical Association 84(7): 322-28, 1994.
  35. Ahroni JH: Teaching foot care creatively and success-fully. The Diabetes Educator 19(4):3 20-5, 1993.
  36. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 15(10): 1386-9, 1992.
  37. Armstrong DG, Lavery LA, Vela SA, et al. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Archives of Internal Medicine 158(3): 289-92, 1998.
  38. Sosenko JM, Sparling YH, Hu D, et al. Use of the Semmes-Weinstein monofilament in the strong heart study. Diabetes Care 22(10): 1715-21,1999.
  39. Smieja M, Hunt DL, Edelman D, et al. Clinical examination for the detection of protective sensation in the feet of diabetic patients. International Cooperative Group for Clinical Examination Research. Journal of General Internal Medicine 14(7): 418-24, 1999.
  40. McGill M, Molyneaux L, Spenser R, et al. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Diabetes Care 22(4): 598-602, 1999. 4 2. Birke JA, Rolfsen RJ. Evaluation of a self-administered sensory testing tool to identify patients at risk of diabetes-related foot problems. Diabetes Care 21(1): 23-5, 1998.
  41. Litzelman DK, Slemenda CW, Langefeld, CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. Annals of Internal Medicine 119(1): 36-41, 1993.
  42. Ollendorf DA, Kotsanos JG, Wishner WJ, et al. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care 21(8): 1240-5, 1998.
  43. Boulton AJ: Lowering the risk of neuropathy, foot ulcers and amputations. Diabetic Medicine 15(Suppl.4): S57-9, 1998.
  44. Larsson J, Apelqvist J, Agardh CD, et al. Decreasing incidence of major amputation in diabetic patients: A consequence of a multidisciplinary foot care team approach? Diabetic Medicine 12(9): 770-6, 1995.
  45. Dargis V, Pantelejeva O, Jonushaite A, et al. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 22(9): 1428-31, 1999.
  46. Rith-Najarian S, Branchaud C, Beaulieu O, et al. Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. Journal of Family Practice 47(2): 127-32, 1998. (See resource list for practice guidelines)
  47. Edelman D, Sanders LJ, Pogach L. Reproducibility and accuracy among primary care providers of a screening examination for foot ulcer risk among diabetic patients. Preventive Medicine 27:274-8, 1998.
  48. Barth R, Campbell LV, Allen S, et al. Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes. Diabetic Medicine 8:111-17, 1991.
  49. Ward A, Metz L, Oddone EZ, et al. Foot education improves knowledge and satisfaction among patients at high risk for diabetic foot ulcer. The Diabetes Educator 25(4): 560-7, 1999.
  50. Suico JG, Marriott DJ, Vinicor F, et al. Behaviors predicting foot lesions in patients with non-insulin dependent diabetes mellitus. Journal of General Internal Medicine 13(7): 482-4, 1998.
  51. Ledda MA, Walker EA. Development and formative evaluation of a foot self-care program for African Americans with diabetes. The Diabetes Educator 23(1): 48-51, 1997.
  52. Caputo GM, Cavanagh PR, Ulbrecht JS, et al. Assessment and management of foot disease in patients with diabetes. New England Journal of Medicine 331(13): 854-60, 1994.
  53. Marchand LH, Campbell W, Rolfsen RJ. Lessons from “Feet Can Last a Lifetime”: A public health campaign. Diabetes Spectrum 9(4): 214-18, 1996.
  54. Thompson FJ, Masson EA. Can elderly diabetic patients co-operate with routine foot care? Age and Aging 21:333-7,1992.
  55. Ruderman N, Devlin JT, Eds. Health Professional’s Guide to Diabetes and Exercise. American Diabetes Association, Alexandria, VA 1996.
  56. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 18(10): 1376-8, 1995.
  57. DeLuca PA, Goforth WP. Effect of shoe color on shoe temperature and potential solar injury to the insensate foot. Journal of the American Podiatric Medical Association 88(7): 344-8, 1998.
  58. Quebedeaux TL, Lavery DC, Lavery LA. The development of foot deformities and ulcers after great toe amputation in diabetes. Diabetes Care 19(2): 165-7, 1996.
  59. Lavery LA, Vela SA, Fleischli JG, et al. Reducing plantar pressure in the neuropathic foot. A comparison of footwear. Diabetes Care 20(11): 1706-10, 1997.
  60. Mueller MJ. Therapeutic footwear helps protect the diabetic foot. Journal of the American Podiatric Medical Association 87(8): 360-4, 1997.
  61. Department of Health and Human Services: Therapeutic shoes for individuals with diabetes. In Medicare Carriers Manual, Section 2134. Washington, D.C., U.S. Govt. Printing Office, July 1994, p.2-85.1-2-86.
  62. Sugarman JR, Reiber GE, Baumgardner G, et al. Use of the therapeutic footwear benefit among diabetic Medicare beneficiaries in three states, 1995. Diabetes Care 21(5): 777-81, 1998.